InVivo Therapeutics Holdings Corp

(NASDAQ:NVIV)

Latest On InVivo Therapeutics Holdings Corp (NVIV):

Date/Time Type Description Signal Details
2023-03-09 20:31 ESTNewsInVivo to evaluate strategic options as trial for spinal injury device failsN/A
2022-10-07 19:34 ESTNewsInVivo Therapeutics dips 24% on $9M direct and private placement offeringsN/A
2022-04-15 02:14 ESTNewsInVivo Therapeutics slumps 7% on 1-for-25 reverse stock splitN/A
2021-09-08 13:34 ESTNewsInVivo Therapeutics provides enrollment update for spinal cord injury studyN/A
2021-07-21 17:48 ESTNewsInVivo Therapeutics soars 15% on FDA acceptance of preclinical module for HDE submissionN/A
2021-03-03 12:09 ESTFinancialsCompany financials have been released.Neutral
2021-02-17 07:24 ESTNewsInVivo is up after peer-reviewed publication of study on spinal cord injuryN/A
2020-11-26 21:02 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 12:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 00:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:40 ESTFinancialsCompany financials have been released.Neutral
2020-10-23 04:47 ESTNewsInVivo Therapeutics under pressure on pricing $15M equity offeringN/A
2020-09-26 13:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:41 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 09:22 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:24 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:21 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:20 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:56 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:19 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:32 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:15 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:37 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 05:44 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 21:02 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 09:21 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 05:49 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 05:20 ESTFinancialsCompany financials have been released.Neutral
2020-04-18 03:08 ESTNewsInVivo Therapeutics launches $3M direct offering; shares down 8% premarketN/A
2020-04-12 06:11 ESTNewsInVivo down 56% after pricing equity offeringN/A
2020-04-03 21:19 ESTFinancialsCompany financials have been released.Neutral
2020-03-12 19:08 ESTInsider TradeC ANN MERRIFIELD has directly acquired 3,636 shares and currently holds 3,639 shares.Buy
2020-03-12 19:08 ESTInsider TradeRICHARD CHRISTOPHER has directly acquired 3,636 shares and currently holds 5,220 shares.Buy
2020-03-12 19:08 ESTInsider TradeRichard M. Toselli has directly acquired 3,636 shares and currently holds 6,069 shares.Buy
2020-02-28 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 21:52 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 21:52 ESTEarnings EstimateAn EPS average of -$10.80 is estimated for the 2021 year.Sell
2020-02-27 21:52 ESTEarnings EstimateAn EPS average of -$5.70 is estimated for the quarter ending on June 30, 2020.Buy
2020-02-27 21:52 ESTEarningsEarnings have been released on March 30, 2020, with -$7.98 earnings per share.Buy
2020-02-23 00:02 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 00:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 00:04 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 00:07 ESTAnalyst RatingThe Analyst Target Price has increased from $1.25 to $37.5.Buy
2020-02-13 00:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 00:19 ESTStock SplitA stock split has occured on Feb 12, 2020 with a split factor of 1:30.Neutral
2020-02-07 00:25 ESTFinancialsCompany financials have been released.Neutral

About InVivo Therapeutics Holdings Corp (NVIV):

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

NVIV Quotes by TradingView

See Advanced Chart

General

  • Name InVivo Therapeutics Holdings Corp
  • Symbol NVIV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 6
  • Last Split Factor1:30
  • Last Split Date2020-02-12
  • Fiscal Year EndDecember
  • IPO Date2010-10-29
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.invivotherapeutics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2
  • Enterprise Value EBITDA 0.59
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Return on Assets -36%
  • Return on Equity -73%
  • Earnings Per Share -$1.30
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 37.6 million
  • EBITDA -11084000
  • Analyst Target Price $37.5
  • Book Value Per Share $0.81
View More

Share Statistics

  • Shares Outstanding 34.18 million
  • Shares Float 34.17 million
  • % Held by Insiders 1235%
  • % Held by Institutions 7.09%
  • Shares Short 3.48 million
  • Shares Short Prior Month 4.12 million
  • Short Ratio 0.58
  • Short % of Float 10%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.71
  • 52 Week High $2.55
  • 52 Week Low $0.5
  • 50 Day Moving Average 1.3
  • 200 Day Moving Average 1.04
View More

Dividends

  • Dividend Date 2020-02-12
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

InVivo Therapeutics Holdings Corp (NVIV) Dividend Calendar:

NVIV's last dividend payment was made to shareholders on February 12, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

InVivo Therapeutics Holdings Corp (NVIV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-03$N/A-$0.09
2020-09-302020-12-31$N/A-$0.13
2020-06-302020-09-30$N/A-$0.47
2020-03-312020-06-30$N/A-$0.49-$5.4090.9%
2019-12-312020-03-31$N/A-$2.47-$9.0072.52%
2019-09-302019-11-07$N/A-$8.70-$9.9012.12%
2019-06-302019-08-13$N/A-$10.20-$9.30-9.68%
2019-03-312019-05-10$N/A-$8.40-$8.703.45%
2018-12-312018-12-31$N/A-$15.30-$10.20-50%
2018-09-302018-11-08$N/A-$12.60-$11.40-10.53%
2018-06-302018-08-07$N/A-$224.40-$12.30-1724.39%
2018-03-312018-05-07$N/A-$100.20-$112.5010.93%
2017-12-312018-03-12$N/A-$97.50-$120.0018.75%
2017-09-302017-10-30$N/A-$210.00-$165.00-27.27%
2017-06-302017-08-08$N/A-$150.00-$153.752.44%
2017-03-312017-05-04$N/A-$150.00-$161.256.98%
2016-12-312017-03-10$N/A-$127.50-$147.5013.56%
2016-09-302016-11-04$N/A-$142.50-$147.503.39%
2016-06-302016-08-04$N/A-$120.00-$159.3824.71%
2016-03-312016-05-06$N/A-$180.00-$195.007.69%
2015-12-312016-03-04$N/A-$105.00-$165.0036.36%
2015-09-302015-11-04$N/A-$64.09
2015-06-302015-08-05$N/A-$0.39-$0.20-95%
2015-03-312015-05-07$N/A-$0.64-$0.05-1180%
2014-12-312015-03-11$N/A-$0.36-$0.16-125%
2014-09-302014-11-05$N/A-$0.04-$0.2080%
2014-06-302014-08-06$N/A-$120.00-$180.0033.33%
2014-03-312014-05-12$N/A-$210.00-$240.0012.5%
2013-12-312014-03-17$N/A-$180.00-$240.0025%
2013-09-302013-11-07$N/A-$210.00-$210.000%
2013-06-302013-08-07$N/A-$570.00-$210.00-171.43%
2013-03-312013-05-09$N/A-$600.00-$210.00-185.71%
2012-12-312013-03-13$N/A-$390.00-$150.00-160%
2012-09-302012-11-14$N/A-$120.00-$150.0020%
2012-06-302012-08-14$N/A-$120.00-$120.000%
2012-03-312012-05-30$N/A$136.93
2011-12-312012-02-29$N/A-$2,031.83
2011-09-302011-09-30$N/A$169.54
2011-06-302011-06-30$N/A-$79.54
2011-03-312011-03-31$N/A-$74.21

InVivo Therapeutics Holdings Corp (NVIV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 1.05 million 1.32 million
Income Before Tax N/A N/A N/A -2.41 million -3.37 million
Selling General Administrative N/A N/A N/A 1.38 million 1.42 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A N/A -2.35 million -2.74 million
Operating Income N/A N/A N/A -2.43 million -2.74 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A -633000
Net Income From Continuing Operations N/A N/A N/A -2.41 million -3.37 million
Net Income Applicable to Common Shares -2.19 million -2.28 million -2.19 million N/A -3.37 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities 69000 -470000 N/A 121000 N/A
Total Cash Flow from Investing Activities -5000 -23000 N/A -12000 N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 6.32 million 367000 N/A
Change to Operating Activities 148000 567000 N/A 550000 N/A
Change in Cash N/A N/A 2.6 million -1.53 million N/A
Total Cash from Operating Activities -1.93 million -1.97 million -3.72 million -1.89 million N/A
Depreciation N/A N/A 80000 81000 N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 56000 45000 N/A 731000 N/A
Capital Expenditures N/A N/A N/A 12000 N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 2.87 million 3.74 million
Total Stockholder Equity N/A N/A N/A 9.56 million 5.58 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A N/A N/A 12.43 million 9.33 million
Common Stock 3000 2000 2000 N/A 2000
Other Current Assets -7000 N/A N/A N/A 4000
Retained Earnings -228.23 million -226.04 million -223.76 million -221.57 million -219.16 million
Other Liabilities 59000 59000 59000 N/A 59000
Other Assets 1.24 million 1.25 million 1.25 million N/A 1.26 million
Cash N/A N/A N/A 9.2 million 6.6 million
Total Current Liabilities 1.97 million 1.87 million N/A 1.87 million 2.66 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 1.01 million 1.08 million 1.15 million N/A 1.28 million
Total Current Assets 19.66 million 8.18 million N/A 9.97 million 6.78 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 19.19 million 7.81 million 10.03 million N/A 5.58 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 481000 587000 N/A 988000 942000

InVivo Therapeutics Holdings Corp (NVIV) Chart:

InVivo Therapeutics Holdings Corp (NVIV) News:

Below you will find a list of latest news for InVivo Therapeutics Holdings Corp (NVIV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

InVivo Therapeutics Holdings Corp (NVIV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest NVIV Trades:

Date Shares Price
Jun 13, 2022 2:47 PM EST100$3.81
Jun 13, 2022 3:38 PM EST100$3.83
Jun 13, 2022 3:38 PM EST100$3.83

InVivo Therapeutics Holdings Corp (NVIV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911020007730/0001179110-20-007730-index.htm
2019-09-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1292519/000000000019013074/0000000000-19-013074-index.htm
2019-09-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1292519/000000000019013550/0000000000-19-013550-index.htm
2019-11-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1292519/000000000019015108/0000000000-19-015108-index.htm
2020-02-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1292519/000000000020001848/0000000000-20-001848-index.htm
2020-03-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1292519/000000000020001888/0000000000-20-001888-index.htm
2020-06-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1292519/000000000020004850/0000000000-20-004850-index.htm
2020-03-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000091957420002457/0000919574-20-002457-index.htm
2020-04-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000091957420003022/0000919574-20-003022-index.htm
2020-10-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000092963820001017/0000929638-20-001017-index.htm
2019-10-28S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000104746919005932/0001047469-19-005932-index.htm
2019-11-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1292519/000104746919006349/0001047469-19-006349-index.htm
2019-11-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1292519/000104746919006460/0001047469-19-006460-index.htm
2020-02-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000104746920000997/0001047469-20-000997-index.htm
2020-03-02S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000104746920001151/0001047469-20-001151-index.htm
2020-03-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000104746920001217/0001047469-20-001217-index.htm
2020-03-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1292519/000104746920001325/0001047469-20-001325-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000104746920001394/0001047469-20-001394-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000104746920002367/0001047469-20-002367-index.htm
2020-04-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1292519/000104746920002369/0001047469-20-002369-index.htm
2020-05-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000104746920003187/0001047469-20-003187-index.htm
2020-06-04424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000104746920003362/0001047469-20-003362-index.htm
2018-06-22424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1292519/000110465918041756/0001104659-18-041756-index.htm
2018-06-26424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1292519/000110465918042287/0001104659-18-042287-index.htm
2018-06-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000110465918043038/0001104659-18-043038-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000110465919008600/0001104659-19-008600-index.htm
2019-06-21POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1292519/000110465919036827/0001104659-19-036827-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465919062061/0001104659-19-062061-index.htm
2019-11-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1292519/000110465919062128/0001104659-19-062128-index.htm
2019-11-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1292519/000110465919063133/0001104659-19-063133-index.htm
2019-11-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000110465919065989/0001104659-19-065989-index.htm
2019-11-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000110465919065990/0001104659-19-065990-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465919065991/0001104659-19-065991-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465919066352/0001104659-19-066352-index.htm
2019-12-108-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465919071457/0001104659-19-071457-index.htm
2020-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920004757/0001104659-20-004757-index.htm
2020-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920006733/0001104659-20-006733-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920009800/0001104659-20-009800-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920016725/0001104659-20-016725-index.htm
2020-02-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920024279/0001104659-20-024279-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920027863/0001104659-20-027863-index.htm
2020-03-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1292519/000110465920028575/0001104659-20-028575-index.htm
2020-04-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000110465920050797/0001104659-20-050797-index.htm
2020-06-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1292519/000110465920068597/0001104659-20-068597-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920070292/0001104659-20-070292-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920090878/0001104659-20-090878-index.htm
2020-10-07S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000110465920112754/0001104659-20-112754-index.htm
2020-10-16S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1292519/000110465920115633/0001104659-20-115633-index.htm
2020-10-26424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1292519/000110465920117863/0001104659-20-117863-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000110465920117865/0001104659-20-117865-index.htm
2020-11-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1292519/000110465920122534/0001104659-20-122534-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911018014176/0001179110-18-014176-index.htm
2019-01-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019000765/0001179110-19-000765-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019000766/0001179110-19-000766-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019000859/0001179110-19-000859-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019002139/0001179110-19-002139-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019004125/0001179110-19-004125-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019005165/0001179110-19-005165-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019006512/0001179110-19-006512-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019008009/0001179110-19-008009-index.htm
2019-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019010713/0001179110-19-010713-index.htm
2019-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019010714/0001179110-19-010714-index.htm
2019-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019010715/0001179110-19-010715-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911019013127/0001179110-19-013127-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911020003589/0001179110-20-003589-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911020003590/0001179110-20-003590-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911020003591/0001179110-20-003591-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000117911020007730/0001179110-20-007730-index.htm
2018-06-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000119312518202479/0001193125-18-202479-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000119312519040169/0001193125-19-040169-index.htm
2020-11-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000119380520001368/0001193805-20-001368-index.htm
2020-04-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000121390020010045/0001213900-20-010045-index.htm
2020-04-28DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1292519/000129251920000002/0001292519-20-000002-index.htm
2018-06-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000153561018000091/0001535610-18-000091-index.htm
2019-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000153561019000037/0001535610-19-000037-index.htm
2020-04-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000153561020000088/0001535610-20-000088-index.htm
2020-11-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1292519/000155335020000963/0001553350-20-000963-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018006578/0001558370-18-006578-index.htm
2018-08-07424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018006619/0001558370-18-006619-index.htm
2018-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837018007171/0001558370-18-007171-index.htm
2018-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837018007575/0001558370-18-007575-index.htm
2018-09-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018007601/0001558370-18-007601-index.htm
2018-09-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018007602/0001558370-18-007602-index.htm
2018-09-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018007603/0001558370-18-007603-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837018007644/0001558370-18-007644-index.htm
2018-10-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018007647/0001558370-18-007647-index.htm
2018-10-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018007648/0001558370-18-007648-index.htm
2018-10-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018007651/0001558370-18-007651-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018008996/0001558370-18-008996-index.htm
2018-11-08424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009003/0001558370-18-009003-index.htm
2018-11-08424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009007/0001558370-18-009007-index.htm
2018-11-08424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009011/0001558370-18-009011-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837018009227/0001558370-18-009227-index.htm
2018-11-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009229/0001558370-18-009229-index.htm
2018-11-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009231/0001558370-18-009231-index.htm
2018-11-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009234/0001558370-18-009234-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837018009403/0001558370-18-009403-index.htm
2018-11-16424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009405/0001558370-18-009405-index.htm
2018-11-16424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009407/0001558370-18-009407-index.htm
2018-11-16424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009411/0001558370-18-009411-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837018009701/0001558370-18-009701-index.htm
2018-12-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009703/0001558370-18-009703-index.htm
2018-12-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009705/0001558370-18-009705-index.htm
2018-12-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837018009707/0001558370-18-009707-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019000048/0001558370-19-000048-index.htm
2019-01-04424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019000049/0001558370-19-000049-index.htm
2019-01-04424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019000052/0001558370-19-000052-index.htm
2019-01-04424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019000053/0001558370-19-000053-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019000142/0001558370-19-000142-index.htm
2019-01-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019000145/0001558370-19-000145-index.htm
2019-01-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019000147/0001558370-19-000147-index.htm
2019-01-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019000148/0001558370-19-000148-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1292519/000155837019002671/0001558370-19-002671-index.htm
2019-04-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1292519/000155837019002673/0001558370-19-002673-index.htm
2019-04-15PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1292519/000155837019003007/0001558370-19-003007-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1292519/000155837019003326/0001558370-19-003326-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019004777/0001558370-19-004777-index.htm
2019-05-17POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1292519/000155837019005188/0001558370-19-005188-index.htm
2019-06-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1292519/000155837019005502/0001558370-19-005502-index.htm
2019-06-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1292519/000155837019005504/0001558370-19-005504-index.htm
2019-06-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1292519/000155837019005695/0001558370-19-005695-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019005696/0001558370-19-005696-index.htm
2019-07-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019006018/0001558370-19-006018-index.htm
2019-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019006077/0001558370-19-006077-index.htm
2019-07-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1292519/000155837019006079/0001558370-19-006079-index.htm
2019-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019006165/0001558370-19-006165-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019008016/0001558370-19-008016-index.htm
2019-09-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1292519/000155837019008578/0001558370-19-008578-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1292519/000155837019008723/0001558370-19-008723-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837019010402/0001558370-19-010402-index.htm
2019-11-08PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1292519/000155837019010629/0001558370-19-010629-index.htm
2019-11-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1292519/000155837019011221/0001558370-19-011221-index.htm
2020-02-2010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1292519/000155837020001077/0001558370-20-001077-index.htm
2020-02-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1292519/000155837020001097/0001558370-20-001097-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837020006492/0001558370-20-006492-index.htm
2020-06-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1292519/000155837020007390/0001558370-20-007390-index.htm
2020-06-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1292519/000155837020007677/0001558370-20-007677-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837020010328/0001558370-20-010328-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1292519/000155837020013154/0001558370-20-013154-index.htm
2019-05-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1292519/999999999519001218/9999999995-19-001218-index.htm
2019-06-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1292519/999999999519001468/9999999995-19-001468-index.htm
2019-11-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1292519/999999999519002574/9999999995-19-002574-index.htm
2020-03-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1292519/999999999520000479/9999999995-20-000479-index.htm
2020-06-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1292519/999999999520001343/9999999995-20-001343-index.htm
2020-10-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1292519/999999999520002952/9999999995-20-002952-index.htm

InVivo Therapeutics Holdings Corp (NVIV) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of InVivo Therapeutics Holdings Corp (NVIV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1235%
Institutional Ownership: 709%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-06-04Richard M. ToselliOfficerSell5,229.000.975,072.130.00https://www.sec.gov/Archives/edgar/data/1292519/000117911019010715/0001179110-19-010715-index.htm
2018-12-18Richard M. ToselliOfficerBuy12,000.0012,000.00https://www.sec.gov/Archives/edgar/data/1292519/000117911018014176/0001179110-18-014176-index.htm
2020-03-10C ANN MERRIFIELDDirectorBuy3,636.003,639.00https://www.sec.gov/Archives/edgar/data/1292519/000117911020003589/0001179110-20-003589-index.htm
2019-09-25RICHARD CHRISTOPHERCFO and TreasurerBuy47,500.0047,500.00https://www.sec.gov/Archives/edgar/data/1292519/000117911019010713/0001179110-19-010713-index.htm
2020-03-10RICHARD CHRISTOPHERCFO and TreasurerBuy3,636.005,220.00https://www.sec.gov/Archives/edgar/data/1292519/000117911020003590/0001179110-20-003590-index.htm
2020-03-10Richard M. ToselliOfficerBuy3,636.006,069.00https://www.sec.gov/Archives/edgar/data/1292519/000117911020003591/0001179110-20-003591-index.htm
2019-09-25Richard M. ToselliOfficerBuy69,000.0079,543.00https://www.sec.gov/Archives/edgar/data/1292519/000117911019010714/0001179110-19-010714-index.htm